| Combined Treatment of Durvalumab, Bevacizumab, Tremelimumab and Transarterial Chemoembolization (TACE) in Subjects With Hepatocellular Carcinoma or Biliary Tract Carcinoma (NCT03937830) | National Cancer Institute (NCI) | 2021-03-10 |
| RT001 in Amyotrophic Lateral Sclerosis (NCT04762589) | Biojiva LLC | 2021-03-10 |
| A Clinical Study Evaluating Inhaled Aviptadil on COVID-19 (NCT04844580) | Centurion Pharma | 2021-03-10 |
| A Rollover Study to Provide Continued Treatment for Participants Previously Enrolled in Studies of Itacitinib (NCT04640025) | Incyte Corporation | 2021-03-10 |
| The Effects of Prucalopride in Patients With Constipation Predominant Irritable Bowel Syndrome (NCT04757493) | Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh | 2021-03-10 |
| Axi-Cel as a 2nd Line Therapy in Patients With Relapsed/Refractory Aggressive B Lymphoma Ineligible to Autologous Stem Cell Transplantation (NCT04531046) | The Lymphoma Academic Research Organisation | 2021-03-10 |
| CHIO3 Trial: CHemotherapy Combined With Immune Checkpoint Inhibitor for Operable Stage IIIA/B Non-Small Cell Lung Cancer (NCT04062708) | Alliance Foundation Trials, LLC. | 2021-03-10 |
| Lenvatinib in Locally Advanced Invasive Thyroid Cancer (NCT04321954) | Massachusetts Eye and Ear Infirmary | 2021-03-09 |
| Safety of Engensis in Participants With Amyotrophic Lateral Sclerosis (NCT04632225) | Helixmith Co., Ltd. | 2021-03-09 |
| Combination Facial Aesthetic Treatment in Millennials (NCT04755595) | State University of New York - Downstate Medical Center | 2021-03-09 |
| Sub-study of Belantamab Mafodotin (GSK2857916) as Monotherapy and in Combination With Dostarlimab (GSK4057190) in Participants With RRMM (NCT06655818) | GlaxoSmithKline | 2021-03-09 |
| A Clinical Study Evaluating Sedation of Intravenous Administration of HSK3486 in ICU Patients Undergoing Long-Term Mechanical Ventilation (NCT04669821) | Haisco Pharmaceutical Group Co., Ltd. | 2021-03-09 |
| Ketamine-enhanced Prolonged Exposure Therapy in PTSD (NCT04560660) | VA Office of Research and Development | 2021-03-09 |
| Re-irradiation With NBTXR3 in Combination With Pembrolizumab for the Treatment of Inoperable Locoregional Recurrent Head and Neck Squamous Cell Cancer (NCT04834349) | M.D. Anderson Cancer Center | 2021-03-09 |
| GEN3014 Trial in Relapsed or Refractory Hematologic Malignancies (NCT04824794) | Genmab | 2021-03-09 |
| Lofexidine Combined With Buprenorphine for Reducing Symptoms of PTSD and OU Relapse in Veterans (NCT04360681) | Pharmacotherapies for Alcohol and Substance Use Disorders Alliance | 2021-03-09 |
| Dose Ranging, Switch Study of Islatravir (MK-8591) and Ulonivirine (MK-8507) Once-Weekly in Virologically-Suppressed Adults With Human Immunodeficiency Virus Type 1 (HIV-1) [MK-8591-013] (NCT04564547) | Merck Sharp & Dohme LLC | 2021-03-09 |
| PM8002 in the Treatment of Patients With Advanced Solid Tumors (NCT05918445) | Biotheus Inc. | 2021-03-09 |
| A Study to Test Whether Different Doses of BI 456906 Help People With Overweight or Obesity to Lose Weight (NCT04667377) | Boehringer Ingelheim | 2021-03-08 |
| A Study of Sintilimab Combined With Concurrent Chemoradiation Therapy in Locally Advanced Cervical Cancer (NCT05105672) | The Affiliated Hospital of Xuzhou Medical University | 2021-03-08 |
| Phase 2 Study Of VLA15, A Vaccine Candidate Against Lyme Borreliosis, In A Healthy Pediatric And Adult Study Population (NCT04801420) | Pfizer | 2021-03-08 |
| A Study of TAK-186 (Also Known as MVC-101) in Adults With Advanced or Metastatic Cancer (NCT04844073) | Takeda | 2021-03-08 |
| A Phase II Clinical Trial Comparing the Efficacy of RO7198457 Versus Watchful Waiting in Patients With ctDNA-positive, Resected Stage II (High Risk) and Stage III Colorectal Cancer (NCT04486378) | BioNTech SE | 2021-03-08 |
| DARA RVD For High Risk SMM (NCT04775550) | Omar Nadeem, MD | 2021-03-08 |
| Preoperative IMRT With Concurrent High-dose Vitamin C and mFOLFOX6 in Locally Advanced Rectal Cancer (NCT04801511) | Zhou Fuxiang | 2021-03-08 |
| A Study of CIN-107 in Adults With Primary Aldosteronism (NCT04605549) | AstraZeneca | 2021-03-08 |
| Trastuzumab Deruxtecan (DS-8201a) for the Treatment of Recurrent or Refractory Osteosarcoma, Wilms Tumor, and Desmoplastic Small Round Cell Tumor (NCT04616560) | National Cancer Institute (NCI) | 2021-03-08 |
| The MONACO Cell Therapy Study: Monocytes as an Anti-fibrotic Treatment After COVID-19 (NCT04805086) | Guy's and St Thomas' NHS Foundation Trust | 2021-03-08 |
| A Diagnostic Study of CD38-Targeted ImmunoPET of Myeloma (NCT04814615) | Hoag Memorial Hospital Presbyterian | 2021-03-08 |
| BNT162b2 Vaccination With 2 Doses in COVID-19 Negative Volunteers and With a Single Dose in COVID-19 Positive Volunteers (NCT04824638) | ANRS, Emerging Infectious Diseases | 2021-03-08 |
| Abscisic Acid Effects on Glucose Homeostasis and Insulin Sensitivity (NCT04722354) | AdventHealth Translational Research Institute | 2021-03-08 |
| SMART Trial: Intrapersonal and Interpersonal Stigma Reduction (NCT04693416) | University of Tennessee | 2021-03-08 |
| Study of Avelumab and/or Radiation Therapy in People With Advanced Merkel Cell Carcinoma (NCT04792073) | Memorial Sloan Kettering Cancer Center | 2021-03-08 |
| Pembrolizumab And Lenvatinib In Leptomeningeal Metastases (NCT04729348) | Massachusetts General Hospital | 2021-03-08 |
| a Clinical Research of BCMA-Targeted Prime CAR-T Cell Therapy in Relapsed/Refractory Multiple Myeloma and Plasma Cell Disease (NCT04776330) | Chongqing Precision Biotech Co., Ltd | 2021-03-07 |
| A Study of Toripalimab or Combining With Temozolomide（iv） in the Treatment of Advanced/Metastatic Malignant Melanoma (NCT04884997) | First Affiliated Hospital of Zhejiang University | 2021-03-07 |
| a Clinical Research of CD19 and CD22 Targeted Prime CAR-T Cell in Relapsed/Refractory B-ALL (NCT04781634) | Chongqing Precision Biotech Co., Ltd | 2021-03-07 |
| Comparative Efficacy & Safety of Dexmedetomidine vs Tramadol in Paeds Hernioraphy. A Caudal Anaesthesia Approach (NCT06735443) | Sahiwal medical college sahiwal | 2021-03-06 |
| Tislelizumab Combined With Anlotinib and Chemotherapy (XELOX) in the Treatment of Advanced Gastric or Gastroesophageal Junction Adenocarcinoma (TALENT) (NCT04963088) | The First Affiliated Hospital with Nanjing Medical University | 2021-03-06 |
| Intensified Chemo-immuno-radiotherapy With Durvalumab for Stage III Non-Small Cell Lung Cancers (NCT04230408) | Latin American Cooperative Oncology Group | 2021-03-05 |
| Honey and Nigella Sativa in COVID-19 Prophylaxis (NCT04767087) | Sohaib Ashraf | 2021-03-05 |
| Docetaxel and Irinotecan in Gastric Cancer (NCT04770623) | Menoufia University | 2021-03-05 |
| Open-label, Non-randomized, Non-comparative, Phase II Study of Safety and Immunogenicity of Combination of AZD1222 and rAd26-S for COVID-19 Prevention (NCT04686773) | R-Pharm | 2021-03-05 |
| Trastuzumab Deruxtecan in Participants With HER2-overexpressing Advanced or Metastatic Colorectal Cancer (NCT04744831) | Daiichi Sankyo | 2021-03-05 |
| Intraperitoneal Injection of Oncolytic Viruses H101 for Patients With Refractory Malignant Ascites (NCT04771676) | Fudan University | 2021-03-05 |
| Surufatinib in Combination With Tislelizumab in Subjects With Advanced Solid Tumors (NCT04579757) | Hutchmed | 2021-03-05 |
| Thrombosomes® in Bleeding Thrombocytopenic Patients Study (NCT04631211) | Cellphire Therapeutics, Inc. | 2021-03-05 |
| Fatty Acid Synthase Inhibition in Castration Refractory Prostate Cancer (NCT04337580) | Wake Forest University Health Sciences | 2021-03-05 |
| Sequential CD19 and CD22 CAR-T Therapy for Newly Diagnosed Ph+ B-ALL (NCT04788472) | Zhejiang University | 2021-03-05 |
| LTX-109 as Treatment for Hidradenitis Suppurativa (NCT04756336) | Pharma Holdings AS | 2021-03-05 |
| Tolerability, Safety and Immunogenicity Trial of the FLU-M® Tetra (NCT05308212) | St. Petersburg Research Institute of Vaccines and Sera | 2021-03-04 |
| The Combination of Immunotherapy and Stereotactic Ablative Radiotherapy in MSS Oligometastatic Colorectal Cancer (NCT04535024) | Fudan University | 2021-03-04 |
| A Study of Axatilimab at 3 Different Doses in Participants With Chronic Graft Versus Host Disease (cGVHD) (NCT04710576) | Syndax Pharmaceuticals | 2021-03-04 |
| The Safety and Efficacy of Fecal Microbiota Transplantation in a Population With Major Depressive Disorder (NCT04805879) | University of Calgary | 2021-03-04 |
| A Phase Ⅱ Study of F520 in Patients With Cervical Carcinoma (NCT06226350) | Shandong New Time Pharmaceutical Co., LTD | 2021-03-04 |
| Platform Trial of Novel Regimens Versus Standard of Care (SoC) in Participants With Non-small Cell Lung Cancer (NSCLC) - Sub-study 2 (NCT06790303) | GlaxoSmithKline | 2021-03-04 |
| Metastatic Solid Cancer Clinical Trial (NCT04739618) | ImmunSYS, LLC | 2021-03-04 |
| CD19-CAR_Lenti T Cells in Pediatric Patients Affected by Relapsed/Refractory CD19+ ALL and DLBCL or PML (NCT04787263) | Bambino Gesù Hospital and Research Institute | 2021-03-04 |
| Adjunctive Acetylsalicylic Acid and Ibuprofen for Tuberculosis (NCT04575519) | Fundació Institut Germans Trias i Pujol | 2021-03-04 |
| Safety and Efficacy of ARQ-252 Cream 0.3% in Subjects With Non-Segmental Facial Vitiligo (NCT04811131) | Arcutis Biotherapeutics, Inc. | 2021-03-04 |
| Teverelix Evaluated in Advanced Prostate Cancer (NCT04693507) | Antev Ltd. | 2021-03-04 |
| Radiation Free Chemotherapy for Early Hodgkin Lymphoma (NCT04866654) | Medical University of Gdansk | 2021-03-04 |
| A Study of JNJ-64304500 as Add-on Therapy in Participants With Active Crohn's Disease (NCT04655807) | Janssen Research & Development, LLC | 2021-03-03 |
| Efficacy and Safety of Belumosudil in Subjects With Diffuse Cutaneous Systemic Sclerosis (NCT04680975) | Kadmon, a Sanofi Company | 2021-03-03 |
| Phase II Study of Olaparib and Pembrolizumab in Advanced Melanoma With Homologous Recombination (HR) Mutation (NCT04633902) | California Pacific Medical Center Research Institute | 2021-03-03 |
| Anti-CD19, Dual Co-stimulatory (4-1BB, CD3ζ) Chimeric Antigen Receptor T-cells in Patients With Relapsed/Refractory Aggressive Lymphoma or Acute Lymphoblastic Leukemia (ALL) (NCT03938987) | University of Alberta | 2021-03-03 |
| Cannabidiol for Prevention of Chemotherapy-induced Peripheral Neuropathy (NCT04582591) | Zealand University Hospital | 2021-03-03 |
| Efficacy and Safety of Tideglusib in Congenital Myotonic Dystrophy (NCT03692312) | AMO Pharma Limited | 2021-03-03 |
| Cabozantinib in Patients With Metastatic Castrate Resistant Prostate Cancer (mCRPC) (NCT04631744) | Weill Medical College of Cornell University | 2021-03-03 |
| Maintenance Oral Etoposide or Observation Following High-dose Chemo for GCT (NCT04804007) | Nabil Adra | 2021-03-03 |
| Prospective Assessment of Patients With Neuroendocrine Tumors and Current or Prior History of Carcinoid Syndrome or Diarrhea Undergoing Peptide Receptor Radionuclide Therapy With or Without Telotristat Ethyl (NCT04713202) | Chandrikha Chandrasekhara | 2021-03-03 |
| Safety and Efficacy of HPP737 in Adult Patients With Plaque Psoriasis (NCT07707141) | Newsoara Biopharma Co., Ltd. | 2021-03-03 |
| A Trial to Learn More About How Well BAY2586116 Works and How Safe it is in Participants With Moderate to Severe Obstructive Sleep Apnea (NCT04713826) | Bayer | 2021-03-03 |
| Beta-blockade With Landiolol in Out-of-hospital Cardiac Arrest (NCT05554978) | Medical University of Vienna | 2021-03-03 |
| Trial of Combined Radiotherapy and Vertebroplasty for Patients With Painful Metastatic Spinal Lesions (NCT04242589) | AHS Cancer Control Alberta | 2021-03-03 |
| Berinert (C1INH) vs Placebo for DGF/IRI (NCT04696146) | Cedars-Sinai Medical Center | 2021-03-03 |
| Allopurinol in Patients With Refractory Angina to Improve Ischemic Symptoms (NCT04368819) | Ministry of Health, Brazil | 2021-03-03 |
| Binimetinib and Imatinib for Unresectable Stage III-IV KIT-Mutant Melanoma (NCT04598009) | University of California, San Francisco | 2021-03-03 |
| Study to Evaluate MET642 in Patients With NASH (NCT04773964) | Metacrine, Inc. | 2021-03-03 |
| Study of Chemotherapy-Free Induction Regimen for Ph+ Acute Lymphoblastic Leukemia With Inotuzumab Ozogamicin (InO) (NCT04747912) | University of Chicago | 2021-03-02 |
| A Study of Atezolizumab Plus Tiragolumab and Atezolizumab Plus Placebo as First-Line Treatment in Participants With Recurrent/Metastatic PD-L1 Positive Squamous Cell Carcinoma of the Head and Neck (NCT04665843) | Hoffmann-La Roche | 2021-03-02 |
| Fluorescent Intra-operative Tumor Margin Examination (NCT04719156) | Kurt Weiss | 2021-03-02 |
| Bendamustine, Rituximab and Acalabrutinib in Waldenstrom's Macroglobulinemia (NCT04624906) | Sunnybrook Health Sciences Centre | 2021-03-02 |
| A Translational and Neurocomputational Evaluation of a Dopamine Receptor 1 Partial Agonist for Schizophrenia (NCT04457310) | Yale University | 2021-03-02 |
| A Study of Auxora in Patients With Critical COVID-19 Pneumonia (NCT04661540) | CalciMedica, Inc. | 2021-03-02 |
| APR-246 in Combination With Acalabrutinib or Venetoclax Based Therapy in Subjects With R/R Non Hodgkin Lymphomas (NHL) (NCT04419389) | Aprea Therapeutics | 2021-03-02 |
| Hypofractionated Radiotherapy Followed by Surgical Resection in the Treatment of Soft Tissue Sarcomas (NCT04506008) | Vanderbilt-Ingram Cancer Center | 2021-03-02 |
| A Diagnostic Imaging Study of 64Cu-SARTATE Using PET on Patients With Known or Suspected Neuroendocrine Tumors (DISCO) (NCT04438304) | Clarity Pharmaceuticals Ltd | 2021-03-02 |
| Effects of APIXaban on BRAIN Protection in Patients With Sinus Rhythm and Heart Failure: APIXBRAIN-HF Trial (NCT04696120) | Korea University Guro Hospital | 2021-03-02 |
| Study of Efficacy and Safety of CRC01 in Adult Large B-cell Lymphoma and B-cell Acute Lymphoblastic Leukemia Patients (NCT04836507) | Curocell Inc. | 2021-03-02 |
| CBD for Dental Pain (NCT04642404) | The University of Texas Health Science Center at San Antonio | 2021-03-01 |
| Clinical Study Evaluating Efficacy and Safety of T3D-959 in Mild-to-moderate AD Subjects (NCT04251182) | T3D Therapeutics, Inc. | 2021-03-01 |
| Evaluation of Naloxegol in the Prevention of POI After Cystectomy (NCT04219046) | Institut Paoli-Calmettes | 2021-03-01 |
| Recovering Damaged Cells for Sequelae Caused by COVID-19, SARS-CoV-2 (NCT04846010) | All Natural Medicine Clinic, LLC | 2021-03-01 |
| A Study of Oral Insulin to Reduce Liver Fat Content in Type 2 Diabetes Patients With Nonalcoholic Steatohepatitis (NASH) (NCT04616014) | Oramed, Ltd. | 2021-03-01 |
| Intravesical Antifibrinolytic for Patients With Hematuria and Clot Retention (NCT04555343) | Fraser Health | 2021-03-01 |
| A Study of HTD1801 in Adolescents With Primary Sclerosing Cholangitis (PSC) (NCT03678480) | HighTide Therapeutics (Hong Kong) Limited | 2021-03-01 |
| Circulating Tumor Cells and Treatment De-escalation After Neoadjuvant Therapy for HER2 Positive Breast Cancer (NCT04993014) | AC Camargo Cancer Center | 2021-03-01 |
| Combination Antiretroviral Therapy (cART) for PBC (NCT03954327) | University of Alberta | 2021-03-01 |
| Clinical Study to Evaluate the Effect of Food Supplement in People Infected With Coronavirus (NCT05446961) | SENAI CIMATEC | 2021-03-01 |